Posted inNews
Delhi High Court grants injunction to GlaxoSmithKline against ‘FEXIT’ marks — “Phonetic similarity in medicines demands stricter scrutiny”; Zee Laboratories restrained
Court’s decision The Delhi High Court granted an interim injunction in favour of GlaxoSmithKline Pharmaceuticals Ltd., restraining Zee Laboratories Limited from using the marks “FEXIT”, “FEXIT-B” and “FEXIT-M” for pharmaceutical…
